DI LENARDA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 9.637
NA - Nord America 7.710
AS - Asia 3.846
SA - Sud America 532
AF - Africa 128
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.880
Nazione #
US - Stati Uniti d'America 7.574
RU - Federazione Russa 3.333
IT - Italia 2.585
PL - Polonia 1.537
SG - Singapore 1.451
CN - Cina 869
SE - Svezia 425
BR - Brasile 407
VN - Vietnam 397
DE - Germania 393
HK - Hong Kong 378
FR - Francia 241
UA - Ucraina 204
NL - Olanda 181
GB - Regno Unito 171
TR - Turchia 156
FI - Finlandia 152
KR - Corea 145
IN - India 101
BG - Bulgaria 91
IE - Irlanda 85
JP - Giappone 73
CA - Canada 63
ES - Italia 49
MX - Messico 44
AR - Argentina 40
BD - Bangladesh 39
BE - Belgio 37
MA - Marocco 36
CH - Svizzera 32
IQ - Iraq 24
PK - Pakistan 24
ID - Indonesia 23
AU - Australia 22
AT - Austria 21
CO - Colombia 20
TG - Togo 20
IR - Iran 18
ZA - Sudafrica 18
EC - Ecuador 17
RO - Romania 17
KZ - Kazakistan 16
PH - Filippine 14
TW - Taiwan 14
PY - Paraguay 13
SA - Arabia Saudita 13
SN - Senegal 13
TH - Thailandia 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 12
PE - Perù 11
DK - Danimarca 10
JO - Giordania 10
MY - Malesia 10
VE - Venezuela 10
DZ - Algeria 9
KE - Kenya 9
CL - Cile 8
HR - Croazia 8
LT - Lituania 8
IL - Israele 7
PT - Portogallo 7
CR - Costa Rica 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
HU - Ungheria 5
KG - Kirghizistan 5
NO - Norvegia 5
NP - Nepal 5
EG - Egitto 4
EU - Europa 4
HN - Honduras 4
LV - Lettonia 4
OM - Oman 4
AL - Albania 3
AM - Armenia 3
BY - Bielorussia 3
EE - Estonia 3
ET - Etiopia 3
JM - Giamaica 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
UY - Uruguay 3
BO - Bolivia 2
BW - Botswana 2
CI - Costa d'Avorio 2
DM - Dominica 2
DO - Repubblica Dominicana 2
GG - Guernsey 2
GR - Grecia 2
MK - Macedonia 2
NI - Nicaragua 2
PR - Porto Rico 2
SI - Slovenia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BH - Bahrain 1
Totale 21.858
Città #
Moscow 3.234
Warsaw 1.460
Singapore 909
Ashburn 848
Fairfield 739
Houston 647
Chandler 536
Woodbridge 511
San Jose 440
Hong Kong 366
Wilmington 353
Ann Arbor 346
Seattle 323
Cambridge 274
Trieste 230
Milan 226
Jacksonville 219
Beijing 218
Rome 188
Seoul 141
Princeton 139
Boardman 118
Ho Chi Minh City 112
Chicago 104
Hefei 101
Izmir 99
Los Angeles 93
Lauterbourg 86
Santa Clara 86
Sofia 86
Dearborn 84
Dublin 82
Columbus 76
Hanoi 73
Helsinki 70
Frankfurt am Main 65
The Dalles 64
Zgierz 64
Munich 62
Council Bluffs 54
London 54
New York 54
São Paulo 48
Turin 46
Düsseldorf 44
Dallas 43
Naples 42
Tokyo 42
San Diego 41
Bologna 37
Bari 35
Buffalo 34
Guangzhou 31
Brussels 30
Casablanca 29
Padova 29
Bremen 27
Grafing 27
Des Moines 26
Florence 26
Nuremberg 25
Redondo Beach 25
Falls Church 24
Shanghai 24
Turku 24
Denver 23
Nanjing 23
Orem 23
Venice 22
Palermo 21
Redwood City 21
Dong Ket 20
Kocaeli 20
Lomé 20
Phoenix 20
Cagliari 19
Udine 19
Verona 19
Genoa 18
Jinan 18
Pune 18
Catania 17
Madrid 17
Montreal 17
Stockholm 17
Amsterdam 16
Atlanta 16
Chennai 16
Modena 16
Ankara 15
Brooklyn 15
Haiphong 15
Norwalk 15
Tianjin 15
Brescia 14
Johannesburg 14
Kunming 14
Bern 13
Da Nang 13
Dakar 13
Totale 15.405
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. 3.329
Continuità assistenziale ospedale-territorio per il paziente con scompenso cardiaco cronico: Una rivoluzione e una sfida nella cura ambulatoriale 1.151
Documento di consenso ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU: Il percorso clinico-diagnostico e terapeutico del paziente con scompenso cardiaco acuto dal domicilio alla dimissione dal Pronto Soccorso/ Dipartimento di Emergenza-Accettazione 794
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study 439
Natural History of Dilated Cardiomyopathy in Children 429
Should we fear direct oral anticoagulants more than vitamin K antagonists in simple single tooth extraction? A prospective comparative study 425
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias 422
Role of Titin Missense Variants in Dilated Cardiomyopathy 416
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 402
Echocardiographic markers of inducible myocardial ischemia at baseline evaluation preparatory to exercise stress echocardiography 367
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 365
Gingival overgrowth caused by Olmesartan Medoxomil: Observational study 352
Conflicting gender-related differences in the natural history of patients with idiopathic dilated cardiomyopathy 346
Multi-state modelling of heart failure care path: A population-based investigation from Italy 344
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 326
La fibrillazione atriale non valvolare: dati dall’Osservatorio delle Malattie Cardiovascolari della provincia di Trieste [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)] 325
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 309
Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up 293
Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? 290
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 266
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 254
Incremental Value of Gait Speed in Predicting Prognosis of Older Adults With Heart Failure. Insights From the IMAGE-HF Study 249
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 247
A new integrated approach to cardiac mechanics: reference values for normal left ventricle 243
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 242
Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut-off criteria. 237
Systolic blood pressure target in systemic arterial hypertension: Is lower ever better? Results from a community-based Caucasian cohort 233
Prognostic role of cardiac calcifications in primary prevention: A powerful marker of adverse outcome highly dependent on underlying cardiac rhythm 230
Personalized support for chronic conditions. A novel approach for enhancing self-management and improving lifestyle. 227
Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based Study 217
Administrative database, observational research and the Tower of Babel 216
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 215
Cardiovascular risk stratification and management of patients with rheumatoid arthritis in clinical practice: The "EPIDAURO registry" 213
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM 212
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Asymptomatic Aortic Stenosis 206
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 204
Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction? 200
Il raggiungimento dei target raccomandati di profilo lipidico in una popolazione con cardiopatia ischemica cronica: dalle linee guida al mondo reale 197
Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure 197
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: Data from the MECKI Score Research Group 196
Atrial fibrillation, cognitive impairment, frailty and disability in older heart failure patients 194
Clinical implications of the CKD epidemiology collaboration (CKD-EPI) equation compared with the modification of diet in renal disease (MDRD) study equation for the estimation of renal dysfunction in patients with cardiovascular disease 192
Cardiomiopatie 2008. Una riflessione a proposito delle recenti classificazioni dell'American Heart Association e del Working Group on Myocardial and Pericardial Diseases della Società Europea di Cardiologia 191
Documento di consenso ANMCO/SIC sulla gestione delle miocarditi 191
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 189
Insights from Cardiac Mechanics after Three Decades from Successfully Repaired Aortic Coarctation 189
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 187
Chronic kidney disease and prognosis in elderly patients with cardiovascular disease: Comparison between CKD-EPI and Berlin Initiative Study-1 formulas 181
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 178
Three dimensional printing of an atrial septal defect: Is it multimodality imaging? 177
HF progression among outpatients with HF in a community setting 175
Response to: “Direct oral anticoagulants, vitamin K antagonists and simple single tooth extraction” 174
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 173
SCN5A Mutations Associate With Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-Sensing Mechanism. 172
Uno sguardo allo scompenso cardiaco con frazione di eiezione preservata: dai trial al mondo reale dell’Osservatorio Cardiovascolare del Friuli-Venezia Giulia 169
Whole exome sequencing identifies a troponin T mutation hot spot in familial dilated cardiomyopathy. 167
Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy. 166
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 164
Comparison of discrimination and calibration performance of ECG-based machine learning models for prediction of new-onset atrial fibrillation 163
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 162
Left ventricular function and exercise performance in idiopathic dilated cardiomyopathy: Role of tissue Doppler imaging 158
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption. 155
[Disease management system in patients with chronic heart failure] 155
Impact of left ventricular hemodynamic forces in adult patients with treated aortic coarctation and preserved left ventricular systolic function 153
Managing heart failure in the very old 151
Prevalence and factors related to inappropriately high left ventricular mass in patients with rheumatoid arthritis without overt cardiac disease 142
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 138
Prognostic value of echocardiographic evaluation of cardiac mechanics in patients with aortic stenosis and preserved left ventricular ejection fraction 133
Effectiveness of PCSK9 inhibitors: A Target Trial Emulation framework based on Real-World Electronic Health Records 133
Heart failure and anemia: Effects on prognostic variables 133
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 129
The hemodynamic power of the heart differentiates normal from diseased right ventricles 124
Sex-related differences in chronic heart failure: a community-based study 121
Wavelet‐Mixed Landmark Survival Models for the Effect of Short‐Term Changes of Potassium in Heart Failure Patients 117
Impact of Atrial Fibrillation on Outcome of Patients with Idiopathic Dilated Cardiomyopathy: Data from the Heart Muscle Disease Registry of Trieste 116
Heart failure patients with improved ejection fraction: insights from the MECKI Score database 110
Diagnosi e cura dell’amiloidosi cardiaca in Italia: risultati della survey della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 107
Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI Score Population) 93
Differences between MINOCA and type 2 myocardial infarction: An ITALIAN observational study 93
What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the MECKI score data-set 93
Is L-PRF an effective hemostatic agent in single tooth extractions? A cohort study on VKA and DOAC patients 91
Tissue Doppler indices of diastolic function as prognosticator in patients without heart failure in primary care 82
Flexible Approaches Based on Multistate Models and Microsimulation to Perform Real-World Cost-Effectiveness Analyses: An Application to Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors 81
LDL Cholesterol Variability Impacts the Prognosis of Patients with Chronic Ischemic Heart Disease: A Real-World Italian Experience 74
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 43
Optimising Return to Work for Cardiovascular Patients: An Interdisciplinary Approach in Occupational Medicine and Cardiology 32
Management of Idiopathic Recurrent Pericarditis in Adults and in Children: A Role for IL-1 Receptor Antagonism 25
Totale 22.361
Categoria #
all - tutte 51.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.776


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021355 0 0 0 0 0 0 0 0 0 154 79 122
2021/20221.281 57 87 67 78 86 132 68 67 142 120 89 288
2022/20231.867 147 205 137 250 177 293 56 168 198 49 126 61
2023/20242.257 106 115 85 99 126 150 233 159 35 176 633 340
2024/20254.954 799 870 549 680 284 233 165 164 307 381 254 268
2025/20265.306 547 285 342 490 524 459 877 305 731 746 0 0
Totale 22.361